SCHEMBL481658

SCHEMBL481658

Cc1cc(-c2cnc(N)cn2)ccc1C(=O)O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GABRP O00591 3/20 0.55
GABRD O14764 3/20 0.55
GABRA1 P14867 3/20 0.55
GABRB1 P18505 3/20 0.55
GABRG2 P18507 3/20 0.55
GABRB3 P28472 3/20 0.55
GABRA5 P31644 3/20 0.55
GABRA3 P34903 3/20 0.55
GABRA2 P47869 3/20 0.55
GABRB2 P47870 3/20 0.55
GABRA4 P48169 3/20 0.55
GABRE P78334 3/20 0.55
GABRA6 Q16445 3/20 0.55
GABRG1 Q8N1C3 3/20 0.55
GABRG3 Q99928 3/20 0.55
GABRQ Q9UN88 3/20 0.55
NEK2 P51955 1/20 0.51
LDHA P00338 3/20 0.50
CAMKK2 Q96RR4 1/20 0.48
ALOX5AP P20292 8/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL40268 0.79 NPC1 (0.51) ALOX5APFEN1NPC1
SCHEMBL15203108 0.78 CSNK2A1 (0.58) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL1498034 0.75 RXRB (0.70) LDHACAMKK2RXRBRXRAKDM4E
SCHEMBL29771992 0.75 RXRB (0.70) LDHACAMKK2RXRBRXRAKDM4E
SCHEMBL18191217 0.73 ALPL (0.55) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL20146789 0.73 CAMKK2 (0.43) GABRPGABRDGABRA1GABRB1GABRG2
Hydrochloric Acid SCHEMBL9150803 0.73 RXRB (0.68) LDHACAMKK2RXRBRXRAKDM4E
Hydrochloric Acid SCHEMBL4365452 0.73 RXRB (0.68) LDHACAMKK2RXRBRXRAKDM4E
SCHEMBL6869349 0.73 TDP1 (0.63) GABRPGABRDGABRA1GABRB1GABRG2
SCHEMBL11972504 0.72 GABRP (0.54) GABRPGABRDGABRA1GABRB1GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2078016-B1 HETEROARYL COMPOUNDS, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH SIGNAL PHARM LLC (US) 2012-02-01 EP disclosed